ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000205041.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.004019377	Resistant
ENSG00000205041.1	ABT-263 (navitoclax)	Sarcoma	0.031925704	Resistant